MANGOCEUTICALS, INC. 8-K

What Happened Mangoceuticals, Inc. (MGRX) filed a Form 8-K on July 2, 2026 disclosing that on June 29, 2026 it entered into a Subscription Agreement with an accredited investor to sell 850,000 restricted shares of common stock at $0.32 per share, raising $272,000. The agreement contains customary representations and warranties and grants the investor piggyback registration rights for one year.

Key Details

• Subscription date: June 29, 2026; Form 8-K filed July 2, 2026.
• Shares issued: 850,000 restricted common shares at $0.32 per share (total proceeds $272,000).
• Registration rights: investor granted piggyback registration rights for one year following the subscription.
• Filing items: Item 1.01 (material definitive agreement) and Item 3.02 (unregistered sale of equity securities); Form of Subscription Agreement attached as Exhibit 10.1.

Why It Matters This transaction is a small equity financing that provides Mangoceuticals with $272,000 in cash and results in issuance of restricted shares, which may dilute existing holders. The piggyback registration rights could allow the investor to join future company-initiated public offerings within one year, potentially affecting future share availability. Investors should review the attached Subscription Agreement (Exhibit 10.1) for full terms.